Citation Impact
Citing Papers
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
2011
Guidelines for Acromegaly Management: An Update
2009
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Genome-wide features of neuroendocrine regulation in Drosophila by the basic helix-loop-helix transcription factor DIMMED
2015 StandoutNobel
Recombinant human thyrotropin-aided versus thyroid hormone withdrawal-aided radioiodine treatment for differentiated thyroid cancer after total thyroidectomy: A meta-analysis
2014
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Adrenergic α2C-Receptors Modulate the Acoustic Startle Reflex, Prepulse Inhibition, and Aggression in Mice
1998 StandoutNobel
The Diagnostic Value of Calcitonin Measurement in Wash-out Fluid from Fine-Needle Aspiration of Thyroid Nodules in the Diagnosis of Medullary Thyroid Cancer
2013
Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study
2013
Kalzitoninbestimmung zur Frühdiagnose des medullären Schilddrüsenkarzinoms
2010
Striking Oxygen Sensitivity of the Peptidylglycine α-Amidating Monooxygenase (PAM) in Neuroendocrine Cells
2015 StandoutNobel
Acromegaly
2006 Standout
Repeat endoscopic transsphenoidal surgery for acromegaly: remission and complications
2013
Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system
1993
Glucopenia-Mediated Release of Somatostatin from Incubated Rat Hypothalamus: Monosaccharide Specificity and Role of Glycolytic Intermediates*
1989
Growth hormone-releasing peptide and its analogues
1995
Sequential hormonal changes in 21 patients with recurrent Cushing's disease after successful pituitary surgery
2011
Radiotherapy and radiosurgery in acromegaly
2008
Pheochromocytoma in multiple endocrine neoplasia type 2: European study
1995
MANAGEMENT OF ENDOCRINE DISEASE: The burden of Cushing's disease: clinical and health-related quality of life aspects
2012
Combination therapy for Cushing’s disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole?
2013
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
1995 Standout
Health‐related quality of life among thyroid cancer survivors: a systematic review
2011
Thyroid cancer
2016 Standout
The Clinical Presentation (Symptoms and Signs) of Sporadic and Familial Chromaffin Cell Tumours (Phaeochromocytomas and Paragangliomas)
2003
Use of the histological pseudocapsule in surgery for Cushing disease: rapid postoperative cortisol decline predicting complete tumor resection
2012
Muscarinic Supersensitivity and Impaired Receptor Desensitization in G Protein–Coupled Receptor Kinase 5–Deficient Mice
1999 StandoutNobel
Familial thyroid cancer: a review
2011
Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin
2010
Studies of the Secretion of Corticotropin-Releasing Factor and Arginine Vasopressin into the Hypophysial-Portal Circulation of the Conscious Sheep
1989
Pheochromocytomas in von Hippel-Lindau Syndrome and Multiple Endocrine Neoplasia Type 2 Display Distinct Biochemical and Clinical Phenotypes
2001
Impact of Routine Measurement of Serum Calcitonin on the Diagnosis and Outcome of Medullary Thyroid Cancer: Experience in 10,864 Patients with Nodular Thyroid Disorders
2004
Stereotactic radiosurgery for Cushing disease: a review
2007
The Thyroid Nodule
2004 Standout
Growth Hormone (GH)-Releasing Peptide-6 Requires Endogenous Hypothalamic GH-Releasing Hormone for Maximal GH Stimulation1
1998
Co-Localization of Growth Hormone Secretagogue Receptor and NPY mRNA in the Arcuate Nucleus of the Rat
1999
Cushing's syndrome
2015 Standout
Acromegaly pathogenesis and treatment
2009
Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons
1994 Standout
Phaeochromocytoma
2005 Standout
Head and neck cancer
2008 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Thyroid Hormone Action on Biosynthesis of Somatostatin by Fetal Rat Brain Cells in Culture*
1988
Pathways to the Secretion of Adrenocorticotropin: A View from the Portal*
1991
Medical Treatment of Cushing's Disease
2013
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)
2010
Human Fetal Pituitary Expresses Functional Growth Hormone-Releasing Peptide Receptors1
1998
Rapid and opposite effects of dexamethasone on in vivo and in vitro hypothalamic somatostatin release
1997
Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin
1996 Nature
Neuropsychiatric Disorders in Cushing’s Syndrome
2010
Results of the Thyroid Cancer Alliance international patient/survivor survey: Psychosocial/informational support needs, treatment side effects and international differences in care
2013
Effect of Obesity and Feeding on the Growth Hormone (GH) Response to the GH Secretagogue L-692,429 in Young Men1
1997
Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice
1997 Standout
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial
2009
New insights into copper monooxygenases and peptide amidation: structure, mechanism and function
2000
Thyroid Nodules: Clinical Importance, Assessment, and Treatment
2007
von Hippel-Lindau disease
2003 Standout
Ghrelin induces adiposity in rodents
2000 StandoutNature
Effect of tianeptine on the hypothalamic somatotropic axis in the conscious sheep
1994
An electrophysiological and morphological investigation of the projections of growth hormone-releasing peptide-6-responsive neurons in the rat arcuate nucleus to the median eminence and to the paraventricular nucleus
1999
cAMP/PKA signaling defects in tumors: Genetics and tissue-specific pluripotential cell-derived lesions in human and mouse
2013
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Growth hormone-releasing hormone and somatostatin concentrations in the hypophysial portal blood of conscious sheep during the infusion of growth hormone-releasing peptide-6
1996
Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.
1996
Persistent Posttreatment Fatigue in Thyroid Cancer Survivors
2014
Treatment of medullary thyroid carcinoma: an update.
2001
A role for ghrelin in the central regulation of feeding
2001 StandoutNature
Thyroid hormones and growth hormone secretion
1992
The corticotropin‐releasing hormone test in the diagnosis of ACTH‐dependent Cushing's syndrome: A reappraisal
2001
Efficacy and tolerability of gamma knife radiosurgery in acromegaly: a 10‐year follow‐up study
2009
Growth hormone-releasing peptide (GHRP)
1998
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 Standout
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
2012 Standout
Hereditary Colorectal Cancer
2003 Standout
Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release
1997
Interrelationship between the Novel Peptide Ghrelin and Somatostatin/Growth Hormone-Releasing Hormone in Regulation of Pulsatile Growth Hormone Secretion
2003
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
2006 Standout
Peptidylglycine α‐amidating monooxygenase: A multifunctional protein with catalytic, processing, and routing domains
1993
Involvement of vasopressin in affective disorders
2008
Molecular Cloning and Gene Expression of Growth Hormone-Releasing Peptide Receptor in Rat Tissues
1998
BAY 43-9006 Inhibition of Oncogenic RET Mutants
2006
Hypophysitis Secondary to Cytotoxic T-Lymphocyte–Associated Protein 4 Blockade
2016
Major Depressive Disorder
2008 Standout
Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center
2012
Cancer immunotherapy — immune checkpoint blockade and associated endocrinopathies
2017
Pheochromocytoma: The Expanding Genetic Differential Diagnosis
2003
Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives
2017
Conventional Pituitary Irradiation Is Effective in Lowering Serum Growth Hormone and Insulin-Like Growth Factor-I in Patients with Acromegaly
2006
A Large Family with Carney Complex Caused by the S147G PRKAR1A Mutation Shows a Unique Spectrum of Disease Including Adrenocortical Cancer
2011
A 6-day intracerebroventricular infusion of the growth hormone-releasing peptide KP-102 stimulates food intake in both non-stressed and intermittently-stressed rats
2000
Pheochromocytoma: Update on Diagnosis, Localization, and Management
1995
Cushing's syndrome
2006 Standout
Pulsatile activation of the hypothalamic-pituitary-adrenal axis during major surgery
1992
Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?
1990
Surgical Interventions and Medical Treatments in Treatment-Naïve Patients With Acromegaly: Systematic Review and Meta-Analysis
2014
Multiple endocrine neoplasia type 2 andRET: from neoplasia to neurogenesis
2000
Association of the M1VPRKAR1AMutation with Primary Pigmented Nodular Adrenocortical Disease in Two Large Families
2009
Mitotane, Metyrapone, and Ketoconazole Combination Therapy as an Alternative to Rescue Adrenalectomy for Severe ACTH-Dependent Cushing's Syndrome
2011
Acute-Phase Proteins and Other Systemic Responses to Inflammation
1999 Standout
Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update
2010
Hexarelin induced growth hormone release is influenced by exogenous growth hormone
1995
Potential Role for Retinoic Acid in Patients with Cushing's Disease
2012
Aberrant G‐protein coupled receptor expression in relation to adrenocortical overfunction
2009
Intrahypothalamic Neurohormonal Interactions in the Control of Growth Hormone Secretion
2007
Growth hormone responses to growth hormone-releasing hormone and hexarelin in fed and fasted dogs: effect of somatostatin infusion or pretreatment with pirenzepine
1998
Tumours of familial origin in the head and neck
2006
Treatment of acromegaly: is there still a place for radiotherapy?
2007
New developments in the medical treatment of Cushing's syndrome
2012
The Use of Preoperative Routine Measurement of Basal Serum Thyrocalcitonin in Candidates for Thyroidectomy due to Nodular Thyroid Disorders: Results from 2733 Consecutive Patients
2010
Endoscopic vs Microsurgical Transsphenoidal Surgery for Acromegaly: Outcomes in a Concurrent Series of Patients Using Modern Criteria For Remission
2013
Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic Shock
2002 Standout
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Quality of Life and Effectiveness Comparisons of Thyroxine Withdrawal, Triiodothyronine Withdrawal, and Recombinant Thyroid-Stimulating Hormone Administration for Low-Dose Radioiodine Remnant Ablation of Differentiated Thyroid Carcinoma
2010
Routine Measurement of Serum Calcitonin is Useful for Early Detection of Medullary Thyroid Carcinoma in Patients with Nodular Thyroid Diseases
2001
Radiosurgery of growth hormone–producing pituitary adenomas: factors associated with biochemical remission
2007
Hypothalamic Growth Hormone Secretagogue-Receptor (GHS-R) Expression Is Regulated by Growth Hormone in the Rat
1997
Mutations in Regulatory Subunit Type 1A of Cyclic Adenosine 5′-Monophosphate-Dependent Protein Kinase (PRKAR1A): Phenotype Analysis in 353 Patients and 80 Different Genotypes
2009
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Approach to the Cushing's Disease Patient With Persistent/Recurrent Hypercortisolism After Pituitary Surgery
2013
Approach to the Patient with Possible Cushing’s Syndrome
2009
A reappraisal of the medical therapy with steroidogenesis inhibitors in C ushing's syndrome
2012
Management of Simple Nodular Goiter: Current Status and Future Perspectives
2003
American Association Of Clinical Endocrinologists, Associazione Medici Endocrinologi, And European Thyroid Association Medical Guidelines For Clinical Practice For The Diagnosis And Management Of Thyroid Nodules
2010 Standout
Structure and Spectroscopy of Copper−Dioxygen Complexes
2004 Standout
Accuracy of repeated measurements of late‐night salivary cortisol to screen for early‐stage recurrence of C ushing's disease following pituitary surgery
2014
Copper Active Sites in Biology
2014 Standout
The structure of cytochrome b561, a secretory vesicle-specific electron transport protein.
1988 StandoutNobel
The Effectiveness of Recombinant Human Thyroid-Stimulating Hormone versus Thyroid Hormone Withdrawal Prior to Radioiodine Remnant Ablation in Thyroid Cancer: A Meta-Analysis of Randomized Controlled Trials
2014
The opiomelanotropinergic neuronal and endocrine systems
1982
Adrenocortical carcinoma: a clinician's update
2011
Nongenomic Transmission Across Generations of Maternal Behavior and Stress Responses in the Rat
1999 StandoutScience
Medullary Thyroid Carcinoma: Management of Lymph Node Metastases
2010
Thyroid abnormalities following the use of cytotoxic T‐lymphocyte antigen‐4 and programmed death receptor protein‐1 inhibitors in the treatment of melanoma
2016
Induction of c-fos Messenger Ribonucleic Acid in Neuropeptide Y and Growth Hormone (GH)-Releasing Factor Neurons in the Rat Arcuate Nucleus Following Systemic Injection of the GH Secretagogue, GH-Releasing Peptide-6*
1997
Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level.
1995
Predictive Value of Serum Calcitonin Levels for Preoperative Diagnosis of Medullary Thyroid Carcinoma in a Cohort of 5817 Consecutive Patients with Thyroid Nodules
2006
Glucocorticoids, Transmitters and Stress
1992
Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis
1995
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
Brown Adipose Tissue: Function and Physiological Significance
2004 Standout
Stereotactic Radiosurgery for Acromegaly
2014
Activation of the Hypothalamo-Pituitary-Adrenal Axis by the Growth Hormone (GH) Secretagogue, GH-Releasing Peptide-6, in Rats
1997
Maternal Care, Hippocampal Glucocorticoid Receptors, and Hypothalamic-Pituitary-Adrenal Responses to Stress
1997 StandoutScience
Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's Syndrome
2007
Cost-Effectiveness of Microsatellite Instability Screening as a Method for Detecting Hereditary Nonpolyposis Colorectal Cancer
2001
Gene Regulation in the Magnocellular Hypothalamo-Neurohypophysial System
2001
LCI699, a Potent 11β-hydroxylase Inhibitor, Normalizes Urinary Cortisol in Patients With Cushing's Disease: Results From a Multicenter, Proof-of-Concept Study
2013
Pheochromocytoma
2002
Gamma Knife surgery for Cushing's disease
2007
Drug Abuse: Hedonic Homeostatic Dysregulation
1997 StandoutScience
Chimeric Antigen Receptor Therapy
2018 Standout
Tumor Recurrence and Hypertension Persistence After Successful Pheochromocytoma Operation
1997
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Low- or High-Dose Radioiodine Remnant Ablation for Differentiated Thyroid Carcinoma: A Meta-Analysis
2013
Monoclonal antibodies to chromaffin cells can distinguish proteins specific to or specifically excluded from chromaffin granules
1987
Calcitonin Measurement in the Evaluation of Thyroid Nodules in the United States: A Cost-Effectiveness and Decision Analysis
2008
Toxicities of Immunotherapy for the Practitioner
2015
Development and activation of brown fat in rats with pheochromocytoma PC 12 tumors
1983
Pitfalls in the diagnosis of Cushing's syndrome
2007
Differential Responsiveness of the Somatotroph to Growth Hormone-Releasing Factor during Early Neonatal Development in the Rat*
1986
Intracerebroventricular administration of the growth hormone-releasing peptide KP-102 increases food intake in free-feeding rats.
1996
Mechanisms Whereby Mononuclear Copper Proteins Functionalize Organic Substrates
1996 Standout
Comparison of Calcium and Pentagastrin Tests for the Diagnosis and Follow-Up of Medullary Thyroid Cancer
2011
Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects.
1996
Risk of Endocrine Complications in Cancer Patients Treated with Immune Check Point Inhibitors: A Meta-Analysis
2016
Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?
2014
Thyroid Nodules: Rational Management
2000
Interleukin-1 Stimulates the Secretion of Hypothalamic Corticotropin-Releasing Factor
1987 StandoutScience
Guidelines for the management of thyroid cancer
2014 Standout
Role of growth hormone (GH)-releasing hormone and somatostatin in the mediation of clonidine-induced GH release in sheep.
1994
Transforming Growth Factor-β: Biological Function and Chemical Structure
1986 StandoutScience
Latin American Thyroid Society recommendations for the management of thyroid nodules
2009
Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin
1983 Nature
MANAGEMENT OF HEREDITARY PHEOCHROMOCYTOMA IN VON HIPPEL-LINDAU KINDREDS WITH PARTIAL ADRENALECTOMY
1999
The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management
2004
Peptidomimetic Regulation of Growth Hormone Secretion
1997
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
1999 StandoutNature
Tumortyp- und tumorstadienorientiertes chirurgisches Konzept bei Karzinomen der Schilddrüse
2010
Patterns of Growth Hormone-Eeleasing Factor and Somatostatin Secretion into the Hypophysial-Portal Circulation of the Rat
1985 Science
γ-Aminobutyric Acid Stimulates Pituitary Growth Hormone Secretion in the Neonatal Rat. A Superfusion Study
1987
Thyroid carcinoma
2003 Standout
Sexual Dimorphism in the Control of Growth Hormone Secretion*
1985
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly-2011 Update
2011
Works of B. Conte‐Devolx being referenced
Long-Term Results of Stereotactic Radiosurgery in Secretory Pituitary Adenomas
2009
A Combined Dexamethasone Desmopressin Test as an Early Marker of Postsurgical Recurrence in Cushing’s Disease
2009
[Hypercalcitoninemia in conditions other than medullary cancers of the thyroid].
1996
Immunoreactive Somatostatin in Rat Hypophysial Portal Blood*
1979
Effect of 41-CRF antiserum on the secretion of ACTH, B-Endorphin and α-MSH in the rat
1983
Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patients. The French Calcitonin Tumours Study Group (GETC)
1999
The desmopressin test as a predictive factor of outcome after pituitary surgery for Cushing's disease
2004
APRKAR1AMutation Associated with Primary Pigmented Nodular Adrenocortical Disease in 12 Kindreds
2006
Outcome of Gamma Knife Radiosurgery in 82 Patients with Acromegaly: Correlation with Initial Hypersecretion
2005
Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study
2008
Merits and pitfalls of mifepristone in Cushing's syndrome
2009
Acute changes in growth hormone-releasing hormone secretion after injection of BIM 23014, a long acting somatostatin analog, in rams
1992
Quality of life in patients at risk of medullary thyroid carcinoma and followed by a comprehensive medical network: Trends for future evaluations
2001
Further studies on the effect of glucose concentrations and other oxidizable substrates upon ionic gradients and in vitro somatostatin release from rat mediobasal hypothalamus
1987
Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease
2007
Gamma knife radiosurgery is a successful adjunctive treatment in Cushing’s disease
2007
2012 European Thyroid Association Guidelines for Genetic Testing and Its Clinical Consequences in Medullary Thyroid Cancer
2012
Phaeochromocytoma in multiple endocrine neoplasia type 2 A: survey of 100 cases
1993
Neostigmine stimulates growth hormone-releasing hormone release into hypophysial portal blood of conscious sheep.
1993
Psychosocial impact of genetic testing in familial medullary-thyroid carcinoma: A multicentric pilot-evaluation
1999
Relationship between hypophyseal portal GHRH and somatostatin and peripheral GH levels in the conscious sheep
1994
Glucocorticoids Regulate Peptidyl-Glycine α-Amidating Monooxygenase Gene Expression in the Rat Hypothalamic Paraventricular Nucleus
1990
Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study
2001
Insulin-induced hypoglycemia stimulates corticotropin-releasing factor and arginine vasopressin secretion into hypophysial portal blood of conscious, unrestrained rams.
1990
Corticotropin-Releasing Factor Secretion Increases in Rat Hypophysial Portal Blood during Insulin-Induced Hypoglycemia
1989
Acute stress stimulates secretion of GHRH and somatostatin into hypophysial portal blood of conscious sheep
1994
Desmopressin test during petrosal sinus sampling: a valuable tool to discriminate pituitary or ectopic ACTH-dependent Cushing’s syndrome
2007
Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients
1998
Characterization of Corticotropin-Releasing Hormone Receptors on Human Pituitary Corticotroph Adenomas and Their Correlation With Endogenous Glucocorticoids*
1988
Interest of Routine Measurement of Serum Calcitonin: Study in a Large Series of Thyroidectomized Patients
1997
In Vitro Corticotropin-Releasing Hormone (CRH) Stimulation of Adrenocorticotropin Release From Corticotroph Adenoma Cells: Effect of Prolonged Exposure to CRH and Its Interaction With Cortisol*
1988
The use of the glucocorticoid receptor antagonist mifepristone in Cushing's syndrome
2012
Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma
2014
Risk and Penetrance of Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A Families with Mutations at Codon 634 of theRETProto-Oncogene1
1998
Early Malignant Progression of Hereditary Medullary Thyroid Cancer
2003
Familial Medullary Thyroid Carcinoma with Noncysteine RET Mutations: Phenotype-Genotype Relationship in a Large Series of Patients
2001
Influence of Endogenous Somatostatin on Growth Hormone and Thyrotropin Secretion in Neonatal Rats*
1982
Influence of haloperidol on ACTH and β-endorphin secretion in the rat
1980
Results of the calcitonin stimulation test in normal volunteers compared with genetically unaffected members of MEN 2A and familial medullary thyroid carcinoma families.
1997
Outcome of multimodal therapy in operated acromegalic patients, a study in 115 patients
2012
[Adrenal tumors of fortuitous discovery. 13 cases].
1987
The Corticotropin-Releasing Factor Release in Rat Hypophysial Portal Blood Is Mediated by Brain Catecholamines
1987
Enkephalins, ACTH, α-MSH and β-endorphin in human pheochromocytomas
1981
Evidence for basal and stress-induced release of corticotropin releasing factor in the push-pull cannulated median eminence of conscious free-moving rats
1987
Adrenocorticotropin,β-Endorphin, and Corticosterone Secretion in Brattleboro Rats*
1982
Effect of nicotine on in vivo secretion of melanocorticotropic hormones in the rat
1981
[Early diagnosis of sporadic medullary cancers of the thyroid: value of systematic assay of calcitonin].
1996
Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep.
1994
Iodine Biokinetics and Radioiodine Exposure after Recombinant Human Thyrotropin-Assisted Remnant Ablation in Comparison with Thyroid Hormone Withdrawal
2010